Dynamic Technology Lab Private Ltd Invests $370,000 in Balchem Co. (NASDAQ:BCPC)

Dynamic Technology Lab Private Ltd purchased a new position in Balchem Co. (NASDAQ:BCPC) during the fourth quarter, Holdings Channel reports. The institutional investor purchased 2,270 shares of the basic materials company’s stock, valued at approximately $370,000.

Several other hedge funds also recently modified their holdings of BCPC. HighTower Advisors LLC increased its stake in shares of Balchem by 15.3% in the 3rd quarter. HighTower Advisors LLC now owns 2,229 shares of the basic materials company’s stock valued at $391,000 after acquiring an additional 295 shares in the last quarter. Stifel Financial Corp increased its stake in shares of Balchem by 26.2% in the 3rd quarter. Stifel Financial Corp now owns 11,893 shares of the basic materials company’s stock valued at $2,093,000 after acquiring an additional 2,467 shares in the last quarter. State Street Corp increased its stake in shares of Balchem by 1.0% in the 3rd quarter. State Street Corp now owns 1,234,226 shares of the basic materials company’s stock valued at $217,224,000 after acquiring an additional 12,006 shares in the last quarter. Orion Portfolio Solutions LLC increased its stake in shares of Balchem by 123.1% in the 3rd quarter. Orion Portfolio Solutions LLC now owns 3,266 shares of the basic materials company’s stock valued at $575,000 after acquiring an additional 1,802 shares in the last quarter. Finally, MML Investors Services LLC increased its stake in shares of Balchem by 6.7% in the 3rd quarter. MML Investors Services LLC now owns 11,341 shares of the basic materials company’s stock valued at $1,996,000 after acquiring an additional 708 shares in the last quarter. Institutional investors own 87.91% of the company’s stock.

Analyst Ratings Changes

BCPC has been the subject of a number of recent research reports. StockNews.com lowered shares of Balchem from a “buy” rating to a “hold” rating in a research note on Tuesday, February 25th. Sidoti raised shares of Balchem to a “hold” rating in a report on Tuesday, February 25th. Finally, HC Wainwright reaffirmed a “buy” rating and set a $190.00 price objective on shares of Balchem in a report on Monday, February 24th.

Balchem Price Performance

BCPC opened at $159.64 on Thursday. The company has a market capitalization of $5.19 billion, a price-to-earnings ratio of 40.62, a P/E/G ratio of 4.41 and a beta of 0.75. The firm’s fifty day moving average price is $164.93 and its two-hundred day moving average price is $168.32. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16. Balchem Co. has a 1 year low of $137.69 and a 1 year high of $186.03.

Balchem (NASDAQ:BCPC) last posted its quarterly earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share for the quarter, missing the consensus estimate of $1.11 by ($0.08). The company had revenue of $240.00 million for the quarter, compared to the consensus estimate of $239.96 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%. As a group, analysts anticipate that Balchem Co. will post 4.64 earnings per share for the current fiscal year.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.